The activation of the nuclear factor kappa light-chain-enhancer of activated B cells (NF-κB) pathway is central to pro-inflammatory signaling driven by SARS-CoV-2 infection and may underlie increased susceptibility to COVID-19 progression. Here, NFKB1 is linked to COVID-19.